Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Patent Publication Number 20210361605

US 20210361605 A1
Patent NumberUS 11744816 B2
Application Number17136870
Filled DateDec 29, 2020
Priority DateMar 13, 2015
Publication DateNov 25, 2021
Original AssigneeEsperion Therapeutics Inc.
Current AssigneeEsperion Therapeutics Inc.
Inventor/ApplicantsNoah Rosenberg
Roger Schofield Newton
Diane Elaine MacDougall
Noah Laban Rosenberg
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.